Secondary hormonal manipulation

A. S. Merseburger, C. Belka, K. Behmenburg, Arnulf Stenzl

3 Zitate (Scopus)

Abstract

Patients with advanced prostate cancer under primary androgen deprivation therapy will practically all develop progression, often associated with an asymptomatic increase in prostate-specific antigen. Recent reports are demonstrating an increased use of androgen deprivation therapy as primary or neoadjuvant treatment; however, meager clinical evidence supports the use of such treatment regimens for localized prostate cancer, except in patients with high-risk or locally advanced prostatic disease. Fortunately, the latter tumors might still be prone to some kind of secondary treatment to block androgen receptors in a primary, secondary or tertiary fashion. Secondary hormonal manipulations for affected patients include antiandrogen withdrawal, second-line antiandrogens, direct adrenal androgen inhibitors, estrogens and progestins. We discuss the emerging concept of secondary hormonal manipulation on the basis of the current literature and demonstrate prospective alternative treatment modalities.

OriginalspracheEnglisch
TitelControversies in the Treatment of Prostate Cancer: 10th International Symposium on Special Aspects of Radiotherapy
Redakteure/-innenLutz Moser, Wolfgang Hinkelbein, Martin Schostak, Kurt Miller
Seitenumfang10
Erscheinungsdatum2008
Seiten93-102
ISBN (Print)9783805585248
DOIs
PublikationsstatusVeröffentlicht - 2008

Strategische Forschungsbereiche und Zentren

  • Profilbereich: Lübeck Integrated Oncology Network (LION)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Secondary hormonal manipulation“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren